Astrazeneca Articles, Photos and Videos

news

AstraZeneca, Pozen Clear E.U. Approval Hurdle for Arthritis Drug Vimovo

Scroll to continue with content AD

Recommended For You

Georgia police officers pose as construction workers to catch people texting and driv…

Jalen Rose says Damian Lillard, CJ McCollum are the most underrated NBA duo

Miss USA 2019 Cheslie Kryst speaks on the migrant crisis: 'I've slept on a floor befo…

More to Explore

astrazeneca

US rejects popular nasal flu vaccine

Pfizer set to buy Allergan for more than $150B

After Market: Best Car Sales Since 2007 Lift Automakers

After Market: New Records Again for Dow, S&P 500

Buyout Blunders: 5 Firms That Should've Said Yes to the Deals

Money Minute: Pink Slime Is Back; Pfizer's AstraZeneca Bid Is Gone

Pfizer Sales Way Off Mark as Drugmaker Pursues AstraZeneca

After Market: Ukraine Strikes Back, Investors Duck for Cover

After Market: A Volatile Roller Coaster Ride on Wall Street

After Market: Modest Gains Stretch S&P 500 Winning Streak

Money Minute: Pfizer Seeks Merger with Reluctant AstraZeneca

Closing Bell: Stocks Slip After Secretary of State Kerry Slams Syria

AstraZeneca to Buy U.S. Cancer Firm for Up to $500M

5 Foreign Stocks You Can Snap Up at Bargain-Basement Prices

Shockingly Few Pharma Ads Comply With FDA Guidelines

The Dark Cloud Over Growing Antidepressant Prescriptions

Record-setting Settlement Says AstraZeneca Lied About Seroquel Effects

WHO's Swine Flu Pandemic Response Wasn't Influenced by Vaccine Makers

The 10 Biggest-Selling Drugs That Are About to Lose Their Patent

Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas

As Diabetes Explodes, Big Pharma Is Gearing Up

Government Recovers $4 Billion from Health Care Fraud Cases

The Top 10 Health Care Stories of 2010

AstraZeneca's Brilinta Fails to Win FDA Approval

FDA Is Set Decide the Fate of AstraZeneca's Heart Drug Brilinta

European Regulators Raid Drugmakers in Collusion Probe

AstraZeneca Looking to Sell Unit for $2 Billion

Earnings, Deals, Hiring: A Busy Day for Big Pharma

AstraZeneca, Pozen Clear E.U. Approval Hurdle for Arthritis Drug Vimovo

Recommended For You

Georgia police officers pose as construction workers to catch people texting and driv…

Jalen Rose says Damian Lillard, CJ McCollum are the most underrated NBA duo

Miss USA 2019 Cheslie Kryst speaks on the migrant crisis: 'I've slept on a floor befo…

When prompted, click “Allow”

You have blocked notifications from Aol.com

astrazeneca

US rejects popular nasal flu vaccine

Pfizer set to buy Allergan for more than $150B

After Market: Best Car Sales Since 2007 Lift Automakers

After Market: New Records Again for Dow, S&amp;P 500

Buyout Blunders: 5 Firms That Should've Said Yes to the Deals

Money Minute: Pink Slime Is Back; Pfizer's AstraZeneca Bid Is Gone

Pfizer Sales Way Off Mark as Drugmaker Pursues AstraZeneca

After Market: Ukraine Strikes Back, Investors Duck for Cover

After Market: A Volatile Roller Coaster Ride on Wall Street

After Market: Modest Gains Stretch S&amp;P 500 Winning Streak

Money Minute: Pfizer Seeks Merger with Reluctant AstraZeneca

Closing Bell: Stocks Slip After Secretary of State Kerry Slams Syria

AstraZeneca to Buy U.S. Cancer Firm for Up to $500M

5 Foreign Stocks You Can Snap Up at Bargain-Basement Prices

Shockingly Few Pharma Ads Comply With FDA Guidelines

The Dark Cloud Over Growing Antidepressant Prescriptions

Record-setting Settlement Says AstraZeneca Lied About Seroquel Effects

WHO's Swine Flu Pandemic Response Wasn't Influenced by Vaccine Makers

The 10 Biggest-Selling Drugs That Are About to Lose Their Patent

Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas

As Diabetes Explodes, Big Pharma Is Gearing Up

Government Recovers $4 Billion from Health Care Fraud Cases

The Top 10 Health Care Stories of 2010

AstraZeneca's Brilinta Fails to Win FDA Approval

FDA Is Set Decide the Fate of AstraZeneca's Heart Drug Brilinta

European Regulators Raid Drugmakers in Collusion Probe

AstraZeneca Looking to Sell Unit for $2 Billion

Earnings, Deals, Hiring: A Busy Day for Big Pharma

AstraZeneca, Pozen Clear E.U. Approval Hurdle for Arthritis Drug Vimovo

Recommended For You

Georgia police officers pose as construction workers to catch people texting and driv…

Jalen Rose says Damian Lillard, CJ McCollum are the most underrated NBA duo

Miss USA 2019 Cheslie Kryst speaks on the migrant crisis: 'I've slept on a floor befo…

When prompted, click “Allow”

You have blocked notifications from Aol.com

After Market: New Records Again for Dow, S&P 500

After Market: Modest Gains Stretch S&P 500 Winning Streak